Purpose: To compare time intensity curve (TIC)-shape analysis of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) data with model-based analysis and semiquantitative analysis in patients with highgrade glioma treated with the antiangiogenic drug bevacizumab.
Materials and Methods:Fifteen patients had a pretreatment and at least one posttreatment DCE-MRI. We applied a pixel-by-pixel TIC shape analysis, where TICs are classified into five different types according to their shape, and calculated the occurrence of each TIC type in the region of interest (ROI). The results were compared to the pharmacokinetic model (PKM) parameters K trans , K ep , V e , and V i , and with the semiquantitative parameters maximum enhancement (ME) and initial slope of increase (ISI).Results: The relative amount of type 2 and 4 TIC shape significantly correlated with the parameter K ep but not with K trans or V e . The PKM parameter V e and the semiquantitative parameters ME and ISI showed significant changes after treatment. None of the TIC shapes individually showed significant changes.
Conclusion:The semiquantitative parameters ME and ISI are more sensitive to the effect of the bevacizumab than K trans and V e . The pixel-by-pixel TIC shape analysis parameters are not sensitive to the effect of bevacizumab, although they can be seen as surrogates for the PKM parameter K ep . DYNAMIC CONTRAST-ENHANCED MAGNETIC RESO-NANCE IMAGING (DCE-MRI) using small molecular weight, gadolinium (Gd)-chelate-based contrast media is widely accepted as a valuable diagnostic aid in cancer imaging, as a mirror of the effect of antitumor drugs, and possibly also as a prognostic tool (1). Several analysis methods can be applied to DCE-MRI, varying from a simple by-eye observation of the timedependent variation in signal intensity after contrast delivery to more sophisticated methods that make use of theoretical pharmacokinetic (PK) models. The application of PK models to the analysis of DCE-MRI data allows the extraction of physiologically relevant quantities that reflect intrinsic properties of the tissue, such as vascular permeability, blood flow, extracellular-extravascular, and vascular volume. Because the quantities measured reflect properties of the tissue and are independent of the MRI settings and parameters that are used to generate them, this analysis method is meant to be a truly quantitative method. First proposed, independently, by Tofts, Brix and Larsson in early 1990 and later refined (2), this PK model is still widely used in cancer imaging: it generates the parameters K trans (the wash-in rate), which describes the forward leakage rate of the contrast medium, K ep (the wash-out constant unit), V e (the extracellular-extravascular space), and V i (the plasma volume). These PK parameters are useful in the differentiation between infective and neoplastic brain lesions (3) and glioma grading (4,5). A plethora of different other models have been proposed (6,7), but Tofts' model remains the most used because of its relative simplici...